SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,424,544 | +14.8% | 191,373 | +30.2% | 0.05% | +13.0% |
| Q2 2023 | $3,854,340 | -89.7% | 147,000 | -89.8% | 0.05% | -90.9% |
| Q1 2023 | $37,255,793 | +183.1% | 1,447,389 | +520.6% | 0.51% | +136.9% |
| Q1 2022 | $13,162,000 | -12.4% | 233,210 | -3.8% | 0.21% | -0.5% |
| Q4 2021 | $15,024,000 | +1678.0% | 242,400 | +1719.0% | 0.22% | +1435.7% |
| Q3 2021 | $845,000 | -89.3% | 13,326 | -86.0% | 0.01% | -90.5% |
| Q2 2021 | $7,867,000 | -39.0% | 95,458 | -45.6% | 0.15% | -48.6% |
| Q1 2021 | $12,899,000 | +37.0% | 175,328 | +35.0% | 0.29% | +14.4% |
| Q4 2020 | $9,415,000 | -11.2% | 129,832 | -41.6% | 0.25% | -28.0% |
| Q3 2020 | $10,601,000 | +55.3% | 222,376 | +36.8% | 0.35% | +28.5% |
| Q2 2020 | $6,826,000 | +19.9% | 162,515 | -22.9% | 0.27% | -33.7% |
| Q1 2020 | $5,694,000 | – | 210,893 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |